Cases & Deals

Burrill Life Sciences Capital Fund, Burrill Indiana Life Sciences Capital Fund, and G. Steven Burrill complete sale of $46.3 million of Common Stock in public offering by Pharmasset

Clients Burrill & Company LLC

Jones Day represented Burrill Life Sciences Capital Fund, L.P., Burrill Indiana Life Sciences Capital Fund, L.P., Delaware limited partnerships, and G. Steven Burrill, as selling stockholders, in connection with the sale of $46.3 million of Common Stock in a public offering by Pharmasset, Inc., a pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.